Reactivation of Hepatitis B After Ibalizumab Therapy for Multidrug-Resistant Human Immunodeficiency Virus

被引：1
|
作者：
Kaplan, Alyson [1 ]
DeHaan, Elliott [2 ]
Maltz, Charles [1 ]
机构：
[1] New York Presbyterian, Dept Med, Div Gastroenterol & Hepatol, Weill Cornell Sch Med, New York, NY 10065 USA
[2] New York Presbyterian, Dept Med, Div Infect Dis, Weill Cornell Sch Med, New York, NY USA
来源：
ACG CASE REPORTS JOURNAL | 2021年 / 8卷 / 05期
关键词：
MONOCLONAL-ANTIBODY; HIV-1;
D O I：
10.14309/crj.0000000000000594
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Despite the decreasing morbidity associated with the human immunodeficiency virus (HIV), a large percentage of persons with HIV have at least 1 drug resistance mutation. Ibalizumab, a recently approved drug, targets multidrug-resistant HIV. We present a case of reactivation of hepatitis B after initiation of ibalizumab therapy.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Reactivation of hepatitis B virus associated with immunosuppression therapy
    Lee, Joseph G. H.
    Carruthers, Mollie
    Ko, Hin Hin
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (43) : E1284 - E1284
  • [42] Hepatitis B virus reactivation in association with antineoplastic therapy
    Yeo W.
    Current Hepatitis Reports, 2009, 8 (3) : 127 - 133
  • [43] Hepatitis B virus reactivation and alemtuzumab therapy.
    Iannitto, E
    Minardi, V
    Calvaruso, G
    Mulè, A
    Ferraro, D
    Ammatuna, E
    Craxì, A
    Abbadessa, V
    Di Stefano, R
    BLOOD, 2004, 104 (11) : 286B - 287B
  • [44] Management of the coinfected patient: Human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C
    Murphy, MJ
    Wilcox, RD
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (01): : 26 - 36
  • [45] Impact of Infection Control Measures to Control an Outbreak of Multidrug-Resistant Tuberculosis in a Human Immunodeficiency Virus Ward, Peru
    Ticona, Eduardo
    Huaroto, Luz
    Kirwan, Daniela E.
    Chumpitaz, Milagros
    Munayco, Cesar V.
    Maguina, Monica
    Tovar, Marco A.
    Evans, Carlton A.
    Escombe, Roderick
    Gilman, Robert H.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (06): : 1247 - 1256
  • [46] Proportion of Multidrug-Resistant Tuberculosis in Human Immunodeficiency Virus/Mycobacterium tuberculosis Co-Infected Patients in Korea
    Joh, Joon Sung
    Hong, H. Christian
    Jeong, In A.
    Chin, Bum Sik
    Yang, Hye Jin
    Choi, Hongjo
    Bang, Ji Hwan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (10) : 1143 - 1146
  • [47] Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus Management Considerations within High-resourced Settings
    Wilson, John W.
    Nilsen, Diana M.
    Marks, Suzanne M.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (01) : 16 - 23
  • [48] Vertical transmission of multidrug-resistant Q151M human immunodeficiency virus type 1 strains
    Henry, Mireille
    Thuret, Isabelle
    Solas, Caroline
    Genot, Severine
    Colson, Philippe
    Tamalet, Catherine
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (03) : 278 - 280
  • [49] Efficacy of Entecavir-Tenofovir Combination Therapy for Chronic Hepatitis B Patients with Multidrug-Resistant Strains
    Lee, Yun Bin
    Lee, Jeong-Hoon
    Lee, Dong Hyeon
    Cho, Hyeki
    Ahn, Hongkeun
    Choi, Won-Mook
    Cho, Young Youn
    Lee, Minjong
    Yoo, Jeong-Ju
    Cho, Yuri
    Cho, Eun Ju
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Kim, Chung Yong
    Lee, Hyo-Suk
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (11) : 6710 - 6716
  • [50] Reactivation of hepatitis B virus after withdrawal of erlotinib
    Bui, N.
    Wong-Sefidan, I.
    CURRENT ONCOLOGY, 2015, 22 (06) : 430 - 432
12345